DALLAS. (Ivanhoe Newswire) — The exact cause of irritable bowel syndrome or IBS is not known, although it affects nearly 45 million Americans, mostly women. New research shows the cause may not be stress or spicy foods, but an accumulation of bacteria in the small intestine.

Three years ago Amanda Martinez began getting bloated and started losing modeling jobs.

Martinez told Ivanhoe, “I would eat chicken broth and get bloated. I would eat a salad and get bloated. You look like you’ve got a baby in your belly. Basically you look like you are 4 months pregnant.”

Kenneth Brown, M.D., a gastroenterologist and chief medical officer for Atrantil said, “One of the reasons why you get so bloated is that bacteria is starting to grow right here in the small intestine.”

Dr. Brown suggested Atrantil, which he developed to attack hard-to-reach bacteria.

“Most people are focusing on the colon. We know the problem starts in the small bowel,” explained Dr. Brown.

Made from quebracho flavonoids, peppermint, and conker tree saponin, and it worked for Martinez when nothing else would.

Dr. Brown told Ivanhoe, “I personally feel like it’s going to give freedom to these people who feel that their guts are controlling their lives.”

Martinez likes the results.

“It’s kind of a miracle cure. I’m going forward. I’m getting jobs. I’m booking like crazy. I’m happy again. I’m able to look at myself in the mirror and feel confident,” said Martinez.

Atrantil is patented and is available without a prescription. The cost to treat irritable bowel syndrome has been reported to be as high as $30 billion.

Contributors to this news report include: Cyndy McGrath, Supervising Producer; Don Wall, Field Producer; Milvionne Chery, Assistant Producer; Brent Sucher, Editor; Mark Montgomery, Videographer.

MEDICAL BREAKTHROUGHS

RESEARCH SUMMARY

TOPIC: Atrantil for IBS

REPORT: MB #4098

BACKGROUND: Irritable bowel syndrome, or IBS, is a common disorder that affects the large intestine. IBS is a chronic condition that needs to be managed long term. Although signs and symptoms are uncomfortable, it doesn’t cause changes in bowel tissue or increase someone’s risk of colorectal cancer. Even though as many as one in five American adults have signs and symptoms of IBS, fewer than one in five who have symptoms seek medical help. There are only a small number of people with IBS that have severe signs and symptoms. Some people can control their symptoms by managing diet, lifestyle and stress, but others will need medication and counseling.

(Source: http://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/basics/definition/con-20024578)

SYMPTOMS: The symptoms of IBS can vary widely from person to person and often resemble those of other diseases. The most common symptoms of IBS include:

· Abdominal pain or cramping

· A bloated feeling

· Gas

· Diarrhea or constipation

· Mucus in the stool

Some symptoms may indicate a more serious condition. If is important to see a doctor if any of the following symptoms occur:

· Rectal bleeding

· Abdominal pain that progresses or occurs at night

· Weight loss

·

(Source: http://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/basics/symptoms/con-20024578)

NEW TECHNOLOGY: Atrantil is a new scientific breakthrough in the treatment of abdominal disorders and small intestinal bacterial overgrowth. In clinical trials of Atrantil, researchers did not see any side effects. Gastroenterologist Kenneth Brown, M.D., said that he gave Atrantil to a patient “because she had bacteria growing where it shouldn’t be, in the small intestine this is what caused the bloating. The bacteria would breakdown the food before her body could and produce gas and bloating.” Dr. Brown also said that not everyone can be treated with this, but he feels confident that probably about 80% of the people with significant bloating and other symptoms of IBS are going to have tremendous relief with Atrantil.

(Source: Dr. Kenneth Brown)

FOR MORE INFORMATION ON THIS REPORT, PLEASE CONTACT:

Kenneth Brown, M.D.

Atrantil

ken@kbsresearch.com